2nd October 2007
Serentis acquires atopic dermatitis company Surface Therapeutics
Cambridge, UK. 2nd October 2007 – Serentis, a UK-based biopharmaceutical company innovating, acquiring and developing dermatological and wound care products, announced today that it has completed the acquisition of Surface Therapeutics Ltd. (“Surface”). Surface has pioneered research into discovering novel, patented treatments for dermatological diseases......read more
3rd July 2007
Serentis Raises £10.3 Million Series A Financing
Cambridge, UK. 3rd July 2007 – Serentis, a Cambridge UK, based biopharmaceutical company focussed on product development announced today that it has completed a £10.3 million ($20.6 million) Series A financing round......read more
